Hints and tips:
Related Special Reports
...This research is different because it drills down into how various types of technology can affect our health, and its measure of worker wellbeing includes both mental and physical health....
...“Plants obtained with new genomic techniques could help build a more resilient and sustainable agri-food system,” said Stella Kyriakides, European commissioner for health and food safety, when launching...
...But it has been bulking up through a series of acquisitions, most recently buying Bayer’s animal-health unit in 2019. The stock is up 15 per cent this year....
...The jab developed with GSK has shown better results in early-phase animal trials, and appears to elicit 10 times more antibodies than the first vaccine. “Here, time plays a role,” said Haas....
...In an animal study, which has yet to be peer reviewed, the companies said the mRNA vaccine could induce antibodies capable of tackling several variants of concern, including Beta, Delta and Lambda....
...CureVac had aimed to produce 300m doses of its vaccine this year and 1bn in 2022 and had a partnership with Bayer to do so....
...Data from Public Health England showed that two doses of the Pfizer vaccine were 88 per cent effective against the Delta variant, and two jabs of the Oxford/AstraZeneca vaccine were 60 per cent effective...
...Germany’s CureVac has teamed up with the country’s largest pharmaceuticals company Bayer to accelerate the development and production of its Covid-19 vaccine....
...Last year, it announced a partnership with pharmaceutical giant Bayer to manufacture its vaccine....
...Competitive advantages Being behind in the race to produce an mRNA Covid-19 vaccine could also end up being a blessing in disguise for CureVac, according to founder Hoerr, 52, who is recovering from his health...
...Medicago grows its vaccine proteins in a plant from the tobacco family, mashing up the leaves into a smoothie to extract what it needs, bypassing the struggles vaccine makers often face when scaling up in animal...
...CureVac also has a manufacturing agreement with Germany’s Bayer. Emma Walmsley, chief executive of GSK, said next generation vaccines would be “crucial” in the fight against Covid-19....
...So too is industry consolidation, most recently exemplified by the $7.6bn merger of Elanco Animal Health and Bayer Animal Health....
...The good news is that Bayer can easily afford to pay. It agreed to sell its animal health unit to Elanco last year for $7.6bn and generated over €4.2bn in free cash flow in 2019....
...The decision to resume crop-spraying follows more than a decade of intense scrutiny of the health risks of glyphosate....
...Temasek this year formed a joint venture with Bayer to develop seeds for vertical farming....
...Of those sums, up to $5bn will be paid out this year, with a further $5bn paid in 2021, financed largely from the company’s existing free cash flow and the proceeds of the sale of its Animal Health business...
...In August, Bayer sold its animal health unit to US group Elanco Animal Health for $7.6bn....
...Bayer has agreed to sell its animal health unit to sector specialist Elanco for $7.6bn, as the German pharmaceuticals and chemicals group sells off assets in the face of mounting legal claims linked to its...
...Bayer’s animal health unit generated ebitda of around $400m last year and in 2017....
...Bayer sold Coppertone to German cosmetics group Beiersdorf for $550m in May. It has yet to conclude the sale of its animal health business, which is expected to fetch up to $8bn....
...(WSJ) News round-up Broadcom in talks to acquire Symantec’s enterprise unit (FT) Elanco, Bayer are aiming to reach animal-health deal next week (BBG) Apollo scores victory over dissident investors (FT...
...Private equity companies are gearing up to battle for Bayer’s animal medicines business in what is likely to be one of Europe’s largest buyouts since the financial crisis....
...For now, consolidation continues: Bayer is said to be considering a merger of its animal division with Elanco Animal Health to rival Zoetis....
...Bayer also confirmed that it is on track to exit its animal health business, and is primarily focused on a sale of the division....
International Edition